Augmented Reality & Virtual Reality In Healthcare Market Set To Grow To Over $780m In 2018

02 August 2018
Pharma

Visiongain has launched a new pharma report Augmented Reality & Virtual Reality in Healthcare Market Forecast 2018-2028: Forecasts by Component (Hardware, Software), Hardware (Head Mounted Display, Heads Up Display, Glasses, Console, Others), Technology (Augmented Reality, Virtual Reality), AR Application (Surgical, Rehabilitation, Training & Medical Education), VR Application (Rehabilitation, Simulation, Diagnostic, Pain Distraction) and Geography, with Profiles of Leading Companies in the AR & VR in Healthcare Market

Virtual and Augmented reality is a suite of hardware, software and service components allowing end-users to visualize and experience virtual environments in real-time. Virtual reality (VR) is an artificial, computer-generated simulation or recreation of a real life environment or situation. It immerses the user by making them feel like they are experiencing the simulated reality first-hand, primarily by stimulating their vision and hearing. Virtual Reality major components include hardware, software and services to provide a virtual environment of real or imaginary subject and further interact with them.

Whereas augmented reality (AR) is a technology that layers computer-generated enhancements atop an existing reality in order to make it more meaningful through the ability to interact with it. AR is developed into apps and used on mobile devices to blend digital components into the real world in such a way that they enhance one another, but can also be told apart easily. In other words, AR includes hardware, software and services to overlay the real-world surrounding with subjects generated through computer generated image. Augmented reality and virtual reality are inverse reflections of one in another with what each technology seeks to accomplish and deliver for the user. Virtual reality offers a digital recreation of a real life setting, while augmented reality delivers virtual elements as an overlay to the real world.

The lead analyst for this report says:

“The study provides ecosystem analysis in order to identify the various participants in the industry along with their role in the ecosystem. It also includes Porter’s five forces analysis, which determines the degree of competition in the market by analysing the bargaining power of buyers and suppliers, as well as the threat of new entrants and substitute products. The market attractiveness tool has been used to analyse the attractiveness of the application segments under consideration.”

The Global market is highly competitive with many different players entering the market. The report discusses products from leading companies in the market. Notable companies in the Augmented Reality & Virtual Reality in Healthcare market include CAE Healthcare, WorldViz, TheraSim, Inc., GE Healthcare., EON Reality, Intuitive Surgical, Inc., Hologic, Inc., LAYAR BV and Siemens Healthineers.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongainglobal.com or call her on +44 (0) 207 336 6100

About Visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

“Oncology remains the largest disease area in the pharmaceutical business. The oncology market is dominated by big pharma companies and high price labels” says Visiongain report

Although price is still the most important competitive advantage for a biosimilar company, current discount rates are not enough to automatically convince the key stakeholders of a biosimilar’s value.

10 September 2019

Read

“Anti-Infective Agents market set to grow to $141bn by 2024” says new Visiongain report

The global anti-infective agents market is one that is driven by innovation. This is vital for maintaining the rich pipeline of anti-infective agents seen in the market today.

09 September 2019

Read

“Global thyroid gland disorder treatment market is anticipated to grow at a lucrative CAGR of 3.6% and anticipated to reach USD 3.21 Billion by 2029”, says Visiongain report.

Thyroid disease is one of today’s most prevalent hormonal illnesses. Hyperthyroidism, hypothyroidism, and thyroid nodules are the most common thyroid gland disorders.

05 September 2019

Read

“Global somatostatin analogs market is anticipated to grow at a lucrative CAGR of 5.3% and anticipated to reach USD 4.78 Bn by 2029”, says Visiongain report.

Somatostatin was used to diagnose gastrointestinal tract tumors and acromegaly in the clinical environment.

05 September 2019

Read